Home › Leiomyosarcoma › Texas › Houston
Leiomyosarcoma clinical trials in Houston, TX
7 studies for Leiomyosarcoma are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
RecruitingPhase 1/2
- UT MD Anderson Cancer Center, Houston
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
RecruitingPhase 3
- M D Anderson Cancer Center, Houston
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
RecruitingPhase 1
- UT MD Anderson Cancer Center, Houston
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
Metastatic Leiomyosarcoma Biomarker Protocol
RecruitingObservational study
- MD Anderson, Houston
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
Leiomyosarcoma trials in other cities
- Boston, MA5 studies
- Chicago, IL4 studies
- Santa Monica, CA4 studies
- Aurora, CO3 studies
- St. Louis, MO3 studies
- Columbus, OH3 studies
- Rochester, MN3 studies
- Nashville, TN3 studies
- Ann Arbor, MI3 studies
- New York City, NY3 studies
- Queens, NY3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)123 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia86 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer62 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.